Delphine works as a director in External Innovation at Lonza, a global drug manufacturing company. She has experience in drug development, commercial development, biomanufacturing & innovation. She is focused on finding interesting technologies in the area of expression systems that drives the company’s R&D innovation pipeline. Expression systems at Lonza include both mammalian cells and microbial organisms, where synthetic biology plays an important role in improving the performance of our bioproduction cell lines.